• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial.

作者信息

Pericàs J M, Moreno A, Almela M, García-de-la-Mària C, Marco F, Muñoz P, Peña C, de Alarcón A, Del Río A, Eworo A, Cruceta A, Paré J C, Mestres C A, Miró J M

机构信息

Infectious Diseases Service, Hospital Clinic, Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

Infectious Diseases Service, Hospital Clinic, Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

出版信息

Clin Microbiol Infect. 2018 Jun;24(6):673-676. doi: 10.1016/j.cmi.2018.01.010. Epub 2018 Feb 3.

DOI:10.1016/j.cmi.2018.01.010
PMID:29408610
Abstract
摘要

相似文献

1
Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial.磷霉素联合亚胺培南与万古霉素治疗耐甲氧西林金黄色葡萄球菌所致复杂性菌血症和心内膜炎的疗效及安全性：一项随机临床试验
Clin Microbiol Infect. 2018 Jun;24(6):673-676. doi: 10.1016/j.cmi.2018.01.010. Epub 2018 Feb 3.
2
Efficacy and safety of fosfomycin plus imipenem as rescue therapy for complicated bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: a multicenter clinical trial.磷霉素联合亚胺培南治疗耐甲氧西林金黄色葡萄球菌引起的复杂性菌血症和心内膜炎的疗效和安全性：一项多中心临床试验。
Clin Infect Dis. 2014 Oct 15;59(8):1105-12. doi: 10.1093/cid/ciu580. Epub 2014 Jul 21.
3
Fatal bacteraemia and infective endocarditis due to meticillin-resistant Staphylococcus aureus (MRSA) with rapid emergence of rifampicin resistance during vancomycin/rifampicin combination treatment.耐甲氧西林金黄色葡萄球菌（MRSA）所致的致死性菌血症和感染性心内膜炎，在万古霉素/利福平联合治疗期间利福平耐药迅速出现。
Int J Antimicrob Agents. 2010 Jun;35(6):615-6. doi: 10.1016/j.ijantimicag.2010.02.009. Epub 2010 Mar 16.
4
Comparative healthcare-associated costs of methicillin-resistant Staphylococcus aureus bacteraemia-infective endocarditis treated with either daptomycin or vancomycin.比较达托霉素与万古霉素治疗耐甲氧西林金黄色葡萄球菌菌血症感染性心内膜炎的相关医疗成本。
Int J Antimicrob Agents. 2016 May;47(5):357-61. doi: 10.1016/j.ijantimicag.2016.02.006. Epub 2016 Mar 19.
5
[Effectiveness and safety of fosfomycin plus imipenem as rescue therapy for bacteremia andendocarditis due to methicillin-resistant Staphylococcus aureus: a multi-center clinical trial ].磷霉素联合亚胺培南作为耐甲氧西林金黄色葡萄球菌所致菌血症和心内膜炎挽救治疗的有效性和安全性：一项多中心临床试验
Med Mal Infect. 2015 Jan-Feb;45(1-2):63-4. doi: 10.1016/j.medmal.2014.10.009.
6
High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis.高剂量达托霉素联合磷霉素治疗耐甲氧西林敏感和耐甲氧西林金黄色葡萄球菌心内膜炎安全有效。
Antimicrob Agents Chemother. 2012 Aug;56(8):4511-5. doi: 10.1128/AAC.06449-11. Epub 2012 May 29.
7
High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus.高万古霉素 MIC 值可预测耐甲氧西林金黄色葡萄球菌所致导管相关血流感染患者发生感染性心内膜炎的风险。
J Antimicrob Chemother. 2017 Jul 1;72(7):2102-2109. doi: 10.1093/jac/dkx096.
8
[Evaluation of pharmacodynamic target attainment with vancomycin treatment of bacteremia due to Staphylococcus aureus methicillin resistant].[万古霉素治疗耐甲氧西林金黄色葡萄球菌所致菌血症时药效学靶点达成情况的评估]
Rev Esp Quimioter. 2010 Mar;23(1):43-7.
9
Efficacy of fosfomycin and its combination with linezolid, vancomycin and imipenem in an experimental peritonitis model caused by a Staphylococcus aureus strain with reduced susceptibility to vancomycin.磷霉素及其与利奈唑胺、万古霉素和亚胺培南联合应用对耐万古霉素金黄色葡萄球菌引起的实验性腹膜炎模型的疗效。
Eur J Clin Microbiol Infect Dis. 2011 Jan;30(1):89-95. doi: 10.1007/s10096-010-1058-0. Epub 2010 Sep 16.
10
Vertebral osteomyelitis caused by vancomycin-tolerant methicillin-resistant Staphylococcus aureus bacteremia: Experience with teicoplanin plus fosfomycin combination therapy.耐万古霉素耐甲氧西林金黄色葡萄球菌菌血症所致脊椎骨髓炎：替考拉宁联合磷霉素治疗经验
J Microbiol Immunol Infect. 2016 Aug;49(4):600-3. doi: 10.1016/j.jmii.2013.09.002. Epub 2013 Nov 21.

引用本文的文献

1
Combination therapy with fosfomycin for bacteraemia or endocarditis: a systematic review and meta-analysis of randomized trials.磷霉素联合治疗菌血症或心内膜炎：随机试验的系统评价和荟萃分析
JAC Antimicrob Resist. 2025 Jun 17;7(3):dlaf101. doi: 10.1093/jacamr/dlaf101. eCollection 2025 Jun.
2
Synergistic activity of fosfomycin and flucloxacillin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus: in vitro and in vivo assessment.磷霉素与氟氯西林对甲氧西林敏感及耐药金黄色葡萄球菌的协同活性：体内外评估
Med Microbiol Immunol. 2025 Jun 21;214(1):32. doi: 10.1007/s00430-025-00841-3.
3
Real-World Use, Effectiveness, and Safety of Intravenous Fosfomycin: The FORTRESS Study.
静脉注射磷霉素的真实世界应用、有效性及安全性：FORTRESS研究
Infect Dis Ther. 2025 Apr;14(4):765-791. doi: 10.1007/s40121-025-01125-2. Epub 2025 Mar 19.
4
New Antimicrobials and New Therapy Strategies for Endocarditis: Weapons That Should Be Defended.感染性心内膜炎的新型抗菌药物及新治疗策略：需加以捍卫的武器
J Clin Med. 2023 Dec 14;12(24):7693. doi: 10.3390/jcm12247693.
5
Treatment of Infective Endocarditis: A Continuing Challenge.感染性心内膜炎的治疗：一项持续的挑战。
Antibiotics (Basel). 2023 Apr 4;12(4):704. doi: 10.3390/antibiotics12040704.
6
Vancomycin, Daptomycin, Antistaphylococcal β-Lactam, and Trimethoprim-Sulfamethoxazole Monotherapy and Combination Therapy in the Management of Methicillin-Resistant : A Network Meta-Analysis.万古霉素、达托霉素、抗葡萄球菌β-内酰胺类药物以及甲氧苄啶-磺胺甲恶唑单药治疗与联合治疗在耐甲氧西林感染管理中的应用：一项网状Meta分析
Front Pharmacol. 2022 May 17;13:805966. doi: 10.3389/fphar.2022.805966. eCollection 2022.
7
Investigational agents for the treatment of methicillin-resistant (MRSA) bacteremia: progress in clinical trials.治疗耐甲氧西林金黄色葡萄球菌（MRSA）菌血症的研究性药物：临床试验进展。
Expert Opin Investig Drugs. 2022 Mar;31(3):263-279. doi: 10.1080/13543784.2022.2040015. Epub 2022 Feb 14.
8
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.用于治疗多重耐药菌引起的新生儿败血症的潜在抗生素
Paediatr Drugs. 2021 Sep;23(5):465-484. doi: 10.1007/s40272-021-00465-z. Epub 2021 Aug 26.
9
A comparison of different antibiotic regimens for the treatment of infective endocarditis.不同抗生素治疗方案用于感染性心内膜炎治疗的比较。
Cochrane Database Syst Rev. 2020 May 14;5(5):CD009880. doi: 10.1002/14651858.CD009880.pub3.
10
New evidence on the use of fosfomycin for bacteremia and infectious endocarditis.磷霉素用于治疗菌血症和感染性心内膜炎的新证据。
Rev Esp Quimioter. 2019 May;32 Suppl 1(Suppl 1):25-29.